These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 28011614)

  • 41. Colistin: how should it be dosed for the critically ill?
    Landersdorfer CB; Nation RL
    Semin Respir Crit Care Med; 2015 Feb; 36(1):126-35. PubMed ID: 25643276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.
    Shotwell MS; Nesbitt R; Madonia PN; Gould ER; Connor MJ; Salem C; Aduroja OA; Amde M; Groszek JJ; Wei P; Taylor ME; Tolwani AJ; Fissell WH
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1377-1383. PubMed ID: 27197907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacokinetics of colistin in patients with cystic fibrosis.
    Reed MD; Stern RC; O'Riordan MA; Blumer JL
    J Clin Pharmacol; 2001 Jun; 41(6):645-54. PubMed ID: 11402633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
    Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL
    Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.
    Hoff BM; Maker JH; Dager WE; Heintz BH
    Ann Pharmacother; 2020 Jan; 54(1):43-55. PubMed ID: 31342772
    [No Abstract]   [Full Text] [Related]  

  • 46. Population pharmacokinetic analysis of colistin in burn patients.
    Lee J; Han S; Jeon S; Hong T; Song W; Woo H; Yim DS
    Antimicrob Agents Chemother; 2013 May; 57(5):2141-6. PubMed ID: 23439640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy and nephrotoxicity associated with colistin use in an intensive care unit in Vietnam: Use of colistin in a population of lower body weight.
    Binh NG; Hayakawa K; Co DX; Tuan ND; Anh NH; Thuy NT; Phuong DM; Huong NT; Thuy PT; Chau NQ; Nhung PH; Gam do TH; Hai DT; Huong TT; Van Anh L; Takeshita N; Ohmagari N
    Int J Infect Dis; 2015 Jun; 35():18-23. PubMed ID: 25835100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study.
    Hua X; Li C; Pogue JM; Sharma VS; Karaiskos I; Kaye KS; Tsuji BT; Bergen PJ; Zhu Y; Song J; Li J
    JMIR Mhealth Uhealth; 2020 Dec; 8(12):e20525. PubMed ID: 33325835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.
    Dalfino L; Puntillo F; Ondok MJ; Mosca A; Monno R; Coppolecchia S; Spada ML; Bruno F; Brienza N
    Clin Infect Dis; 2015 Dec; 61(12):1771-7. PubMed ID: 26354965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
    Markou N; Fousteri M; Markantonis SL; Zidianakis B; Hroni D; Boutzouka E; Baltopoulos G
    J Antimicrob Chemother; 2012 Oct; 67(10):2459-62. PubMed ID: 22790220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.
    Kristoffersson AN; Rognås V; Brill MJE; Dishon-Benattar Y; Durante-Mangoni E; Daitch V; Skiada A; Lellouche J; Nutman A; Kotsaki A; Andini R; Eliakim-Raz N; Bitterman R; Antoniadou A; Karlsson MO; Theuretzbacher U; Leibovici L; Daikos GL; Mouton JW; Carmeli Y; Paul M; Friberg LE
    Clin Microbiol Infect; 2020 Dec; 26(12):1644-1650. PubMed ID: 32213316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy.
    Ozel AS; Ergönül Ö; Korten V
    J Infect Dev Ctries; 2019 Oct; 13(10):877-885. PubMed ID: 32084017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergent renal dysfunction with colistin pharmacotherapy.
    Collins JM; Haynes K; Gallagher JC
    Pharmacotherapy; 2013 Aug; 33(8):812-6. PubMed ID: 23606349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Changes in the dosing of colistimethate sodium in critically ill patients].
    Ortega-García MP; Abril-López de Medrano V; Gimeno-Cardona C
    Rev Esp Quimioter; 2016 Feb; 29(1):53-4. PubMed ID: 26785228
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis.
    Koomanachai P; Landersdorfer CB; Chen G; Lee HJ; Jitmuang A; Wasuwattakul S; Sritippayawan S; Li J; Nation RL; Thamlikitkul V
    Antimicrob Agents Chemother; 2014; 58(1):440-6. PubMed ID: 24189256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of renal replacement therapy on pharmacokinetics in critically ill patients.
    Bugge JF
    Best Pract Res Clin Anaesthesiol; 2004 Mar; 18(1):175-87. PubMed ID: 14760881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
    Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
    Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement Therapy.
    Menna P; Salvatorelli E; Mattei A; Cappiello D; Minotti G; Carassiti M
    Chemotherapy; 2018; 63(1):35-38. PubMed ID: 29334366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.
    Boisson M; Jacobs M; Grégoire N; Gobin P; Marchand S; Couet W; Mimoz O
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7331-9. PubMed ID: 25267660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.